Marianne De Backer

CIK: 0001797819

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VIR

Vir Biotechnology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

VIR
Vir Biotechnology, Inc.
Apr 29, 2026
Other(J)
Direct
233.5K shares-
VIR
Vir Biotechnology, Inc.
Apr 29, 2026
Other(J)
Indirect
233.5K shares-
VIR
Vir Biotechnology, Inc.
Apr 6, 2026
Sale(S)
Direct
72.6K shares at avg. $9.16$664K
VIR
Vir Biotechnology, Inc.
Feb 24, 2026
Sale(S)
Direct
14.8K shares at avg. $9.53$141K
VIR
Vir Biotechnology, Inc.
Feb 23, 2026
Sale(S)
Direct
19K shares at avg. $7.45$142K
VIR
Vir Biotechnology, Inc.
Feb 22, 2026
Award(A)
Direct
285K shares-
VIR
Vir Biotechnology, Inc.
Apr 3, 2025
Sale(S)
Direct
79.7K shares at avg. $5.95$474K
VIR
Vir Biotechnology, Inc.
Feb 24, 2025
Sale(S)
Direct
16.1K shares at avg. $9.45$152K
VIR
Vir Biotechnology, Inc.
Feb 22, 2025
Award(A)
Direct
240K shares-

		Type	Shares	Price		Ownership
Apr 29, 2026	VIR Vir Biotechnology, Inc.	Other(J)	233,532	-	$0	Direct
Apr 29, 2026	VIR Vir Biotechnology, Inc.	Other(J)	233,532	-	$0	Indirect
Apr 6, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	72,559	$9.16	$664,350	Direct
Feb 24, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	14,762	$9.53	$140,720	Direct
Feb 23, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	19,039	$7.45	$141,894	Direct
Feb 22, 2026	VIR Vir Biotechnology, Inc.	Award(A)	285,000	-	$0	Direct
Apr 3, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	79,712	$5.95	$474,239	Direct
Feb 24, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	16,122	$9.45	$152,408	Direct
Feb 22, 2025	VIR Vir Biotechnology, Inc.	Award(A)	240,000	-	-	Direct

1-9 of 9 transactions

About De Backer Marianne

De Backer Marianne (SEC CIK 0001797819) files insider reports with the SEC as President and CEO of Vir Biotechnology, Inc. (VIR).

Signal8 holds 6 ownership filings by De Backer Marianne, all Form 4s, filed between Feb 25, 2025 and Apr 30, 2026. Those filings report 9 transactions, from Feb 22, 2025 to Apr 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on De Backer Marianne's filings is in SAN FRANCISCO, CA.

Recent filings by De Backer Marianne

Apr 29, 2026: Other transactions of VIR shares (2 lines, Form 4, code J).
Apr 6, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 24, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 23, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 22, 2026: Grant or award of VIR shares (Form 4, code A).

Other insiders filing for Vir Biotechnology, Inc. (VIR)

Topalian Suzanne Louise, Director
Sawaf Aziz, EVP, Chief Financial Officer
MORE ROBERT J, Director
Coughlin Timothy, Director
Napolitano Janet, Director
Sabatini Brent, SVP, Chief Accounting Officer

How to read Form 4 transaction codes